ESC CVD Risk Calculation 4+

Name: ESC CVD Risk Calculation
Rating: 4.5 (15 reviews)
Author: ESC - European Society of Cardiology

ESC - European Society of Cardiology

Được thiết kế cho iPad

- 4,5 • 15 đánh giá

- Miễn phí

Miêu tả

The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk. It includes calculators for primary and secondary prevention in various populations:

1. SCORE2
2. SCORE2-OP
3. SCORE2-Diabetes
4. ASCVD
5. SMART
6. SMART-REACH*
7. DIAL*
8. LIFE-CVD*

* Available online on U-Prevent (Internet connection required)

The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App.

This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance.

This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC.

The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit.

The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific content within the Application.

18 thg 8, 2023

Phiên bản 1.3

1. Introducing SCORE2-Diabetes 10-year CVD Risk Calculator: A powerful new calculator to assess your 10-year Cardiovascular Disease (CVD) risk with diabetes consideration. This new calculator replaces the ADVANCE calculator from previous versions
2. Improved Results Page: The result page provides cleaner and clearer information.
3. Removed LDL C option and instruction "add LDL cholesterol to evaluate treatment effect..." from SCORE2, SCORE2-OP, SCORE2-Diabetes, SMART and ASCVD

4,5/5

15 đánh giá

Nhà phát triển, ESC - European Society of Cardiology, đã cho biết rằng phương thức đảm bảo quyền riêng tư của ứng dụng có thể bao gồm việc xử lý dữ liệu như được mô tả ở bên dưới. Để biết thêm thông tin, hãy xem chính sách quyền riêng tư của nhà phát triển.